MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer

Area of Science:

• Molecular Biology
• Epigenetics
• Cancer Research

Background:

• Mediator of DNA damage checkpoint protein 1 (MDC1) is crucial for DNA damage response.
• The role of MDC1 in gene transcription and prostate cancer (PCa) pathogenesis is not fully understood.
• Androgen receptor (AR) signaling is central to PCa, regulating genes that influence tumor progression.

Purpose of the Study:

• To investigate the function of MDC1 in modulating AR transcriptional activity independently of DNA damage.
• To elucidate the mechanisms by which MDC1 influences AR target gene expression.
• To determine the role of MDC1 as a potential tumor suppressor in PCa.

Main Methods:

• Functional identification of MDC1 as an AR co-activator.
• Assessment of MDC1's role in facilitating AR-GCN5 interaction and histone H3 acetylation.
• Analysis of MDC1 depletion effects on PCa cell growth, migration, and AR target gene expression (p21, Vinculin).
• Correlation analysis of MDC1 and p21 expression with clinical PCa phenotypes.

Main Results:

• MDC1 acts as a co-activator for AR, enhancing histone H3 acetylation at AR target gene regulatory elements via GCN5.
• MDC1 knockdown promotes PCa cell proliferation and migration.
• Depletion of MDC1 reduces the expression of androgen-induced genes, including p21 and Vinculin, in AR-positive PCa cells.
• Lower expression of MDC1 and p21 correlates with more aggressive PCa phenotypes.

Conclusions:

• MDC1 functions as an epigenetic modifier regulating AR transcriptional activity.
• MDC1 may act as a tumor suppressor in prostate cancer.
• These findings offer insights into AR co-factor mechanisms and MDC1's function in PCa.